![](https://celsci.jaxbull.com/wp-content/uploads/2018/08/pexels-photo-1170979.jpeg)
About us
BUSINESS STRATEGY
CEL-SCI Corporation (NYSE MKT: CVM), a biotechnology company, was formed in 1983. CEL-SCI is involved in the research and development of immunotherapy products for the treatment of cancer and infectious diseases. The Company's core capabilities include: drug discovery, research, development and manufacturing of complex biological substances.
Read more...V CEL-SCI's vision is to change the way cancer is treated. We strive to develop novel immune-based therapies with potential to utilize the body's own immune defense system against the disease with the possibility of minimal toxicity to normal cells and organ systems. CEL-SCI's lead investigational therapy, Multikine® (Leukocyte Interleukin, Injection), is currently being developed as a potential therapeutic agent directed at enabling the immune system to use the body's own anti-tumor immune response.
V CEL-SCI's vision is to change the way cancer is treated. We strive to develop novel immune-based therapies with potential to utilize the body's own immune defense system against the disease with the possibility of minimal toxicity to normal cells and organ systems. CEL-SCI's lead investigational therapy, Multikine® (Leukocyte Interleukin, Injection), is currently being developed as a potential therapeutic agent directed at enabling the immune system to use the body's own anti-tumor immune response.
Mission & Values
Hired profesors, doctors
and other specialist in our
hospital
OUR STAFF
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Nulla mauris dolor.
![Untitled design (54) Untitled design (54)](https://celsci.jaxbull.com/wp-content/uploads/2018/08/Untitled-design-54.png)
Prof. Lorena
Mitrenson
Duis dignissim mi ut laoreet mollis. Nunc id tellus finibus, eleifend mi vel, maximus justo. Maecenas mi tortor.
![home_clinic2_pic3 home_clinic2_pic3](https://celsci.jaxbull.com/wp-content/uploads/2017/08/home_clinic2_pic3.png)
Prof. Jepherson
Shulter
Curabitur sed iaculis dolor, non congue ligula. Maecenas imperdiet ante eget hendrerit posuere. Nunc urna.
![home_clinic2_pic4 home_clinic2_pic4](https://celsci.jaxbull.com/wp-content/uploads/2017/08/home_clinic2_pic4.png)
Prof. Marcus
Filtz
Sed ultrices nisl velit, eu ornare est ullamcorper a. Nunc quis nibh magna. Proin risus erat, fringilla vel purus sit.
![home_clinic2_pic7 home_clinic2_pic7](https://celsci.jaxbull.com/wp-content/uploads/2017/08/home_clinic2_pic7.png)
Prof. Lorena
Mitrenson
Duis dignissim mi ut laoreet mollis. Nunc id tellus finibus, eleifend mi vel, maximus justo. Maecenas mi tortor.
![home_clinic2_pic8 home_clinic2_pic8](https://celsci.jaxbull.com/wp-content/uploads/2017/08/home_clinic2_pic8.png)
Prof. Jepherson
Shulter
Curabitur sed iaculis dolor, non congue ligula. Maecenas imperdiet ante eget hendrerit posuere. Nunc urna.
![home_clinic2_pic9 home_clinic2_pic9](https://celsci.jaxbull.com/wp-content/uploads/2017/08/home_clinic2_pic9.png)
Prof. Marcus
Filtz
Sed ultrices nisl velit, eu ornare est ullamcorper a. Nunc quis nibh magna. Proin risus erat, fringilla vel purus sit.
![home_clinic2_pic2 home_clinic2_pic2](https://celsci.jaxbull.com/wp-content/uploads/2017/08/home_clinic2_pic2.png)
Prof. Lorena
Mitrenson
Duis dignissim mi ut laoreet mollis. Nunc id tellus finibus, eleifend mi vel, maximus justo. Maecenas mi tortor.